What is the current market valuation of the diabetic retinopathy market in South Korea as of 2024?

The market valuation was $244.2 Million in 2024. Read More

What is the projected market size for diabetic retinopathy in South Korea by 2035?

The projected market size is $532.1 Million by 2035. Read More

What is the expected CAGR for the diabetic retinopathy market in South Korea during the forecast period 2025 - 2035?

The expected CAGR is 7.34% during the forecast period 2025 - 2035. Read More

Which companies are the key players in the South Korean diabetic retinopathy market?

Key players include Novartis, Regeneron Pharmaceuticals, Roche, Bayer, Pfizer, Alimera Sciences, Santen Pharmaceutical, Horizon Therapeutics, and Eyenovia. Read More

What are the main segments of the diabetic retinopathy market in South Korea?

The main segments include Type, Treatment, and End User. Read More

What was the market valuation for Non-Proliferative Diabetic Retinopathy (NPDR) in 2024?

The market valuation for NPDR was $122.1 Million in 2024. Read More

How much is the Proliferative Diabetic Retinopathy (PDR) segment expected to grow by 2035?

The PDR segment is projected to grow to $266.0 Million by 2035. Read More

What are the projected revenues for pharmacological therapies in the diabetic retinopathy market by 2035?

Projected revenues for pharmacological therapies are expected to reach $180.0 Million by 2035. Read More

What is the expected revenue for laser treatment in the diabetic retinopathy market by 2035?

The expected revenue for laser treatment is projected to be $200.0 Million by 2035. Read More

Which end user segment is anticipated to have the highest revenue by 2035?

The Hospitals & Clinics segment is anticipated to have the highest revenue, projected at $220.0 Million by 2035. Read More

South Korea Diabetic Retinopathy Market

ID: MRFR/HC/48705-HCR

200 Pages

Vikita Thakur

Last Updated: April 24, 2026

South Korea Diabetic Retinopathy Market Research Report: Size, Share, Trend Analysis By Types (Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR), By Treatment (Pharmacological Therapies, Laser Treatment, Surgery), and By End-user (Hospitals & Clinics, Ophthalmology Centers, Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Diabetic Retinopathy Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  1. 4.1.1 Non-Proliferative Diabetic Retinopathy (NPDR)
  2. 4.1.2 Proliferative Diabetic Retinopathy (PDR)
2. 4.2 Food, Beverages & Nutrition, BY Treatment (USD Million)
  1. 4.2.1 Pharmacological Therapies
  2. 4.2.2 Laser Treatment
  3. 4.2.3 Surgery
3. 4.3 Food, Beverages & Nutrition, BY End User (USD Million)
  1. 4.3.1 Hospitals & Clinics
  2. 4.3.2 Ophthalmology Centers
  3. 4.3.3 Research Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Novartis (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Regeneron Pharmaceuticals (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bayer (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Pfizer (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Alimera Sciences (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Santen Pharmaceutical (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Horizon Therapeutics (IE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Eyenovia (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY TREATMENT
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
8. 6.8 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
9. 6.9 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
11. 6.11 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 (% SHARE)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 TO 2035 (USD Million)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

Non-Proliferative Diabetic Retinopathy (NPDR)
Proliferative Diabetic Retinopathy (PDR)

Food, Beverages & Nutrition By Treatment (USD Million, 2025-2035)

Pharmacological Therapies
Laser Treatment
Surgery

Food, Beverages & Nutrition By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ophthalmology Centers
Research Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”